3-Bromo-5-methoxyimidazo[1,2-a]pyridine

Catalog No. :
ACKSYN957
CAS No. :
1367950-29-5
Molecular Formula :
C8H7BrN2O
Molecular Weight :
227.06

IUPAC Name:3-bromo-5-methoxyimidazo[1,2-a]pyridine

3-Bromo-5-methoxyimidazo[1,2-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$97.00Login to see priceIn stockInquiry
5g97%$313.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-methoxyimidazo[1,2-a]pyridine
IUPAC Name3-bromo-5-methoxyimidazo[1,2-a]pyridine
MDL No.MFCD22035691
Molecular FormulaC8H7BrN2O
Molecular Weight227.06
SMILESCOC1=CC=CC2=NC=C(Br)N12
InChI KeyYXYKYJLIHFAPQR-UHFFFAOYSA-N
Synonym3-bromo-5-methoxyimidazo[1,2-a]pyridine | 1367950-29-5 | Imidazo[1,2-a]pyridine, 3-bromo-5-methoxy- | 3-bromo-5-methoxy-imidazo[1,2-a]pyridine | SCHEMBL6765637 | AT28754 | PB40432 | BS-27347 | CS-0445551 | imidazo[1,2-a]pyridine,3-bromo-5-methoxy-
CAS No.1367950-29-5
PubChem CID22726185

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACKSYN957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACKSYN957 route product structure diagram
    ACKSYN9571367950-29-5 In Stock
Inquiry

2. ACKSYN957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKSYN957 route product structure diagram
    ACKSYN9571367950-29-5 In Stock
Inquiry

Comments (0)